OBJECTIVES The only known curative therapy for primary myelofibrosis is allogeneic hematopoietic stem cell transplant. MATERIALS AND METHODS We retrospectively evaluated 11 transplant procedures involving 10 patients (5 men and 5 women) diagnosed with primary myelofibrosis between 2005 and 2014. RESULTS The median age at the time of transplant was 60.5 years (range, 22-62 years). Stem cell ...

Myelodysplastic syndrome (MDS) is a hemopoietic stem cell disorder that is potentially curable by transplantation of normal hemopoietic stem cells. The optimum timing, however, and the best conditioning strategy have remained controversial. Both conventional and reduced-intensity/nonmyeloablative regimens have been used successfully. Among selected patients with less advanced/low-risk MDS (< 5%...

suBMissiON Abstracts can be submitted for the BMT Tandem Meetings on either of the two Web sites. The deadline is october 8. HOusiNG lodging accommodations also can be accessed on either Web site. The housing deadline is January 11, 2008, after which accommodations are on a space-available basis. BlOOD sTeM Cell TRANsPlANTs eXCeeD 16,000 yeARly iN u.s. Currently more than 16,000 hematopoietic s...

munoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998;91:141-57. 6. Skinner M, Sanchorawala V, Seldin DC, et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004;140:85-93. 7. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337:898-909. 8. Kyle RA, Greipp PR. Amyloi...

Infectious disease is common in stem cell transplant recipients, especially in the patients of primary immunodeficiency disease (PID). However, there’s little report about sepsis and meningitis caused by enterococcus faecium (EF). Meningitis and sepsis caused by EF is uncommon in stem cell transplant recipients. We report a case of EF meningitis and sepsis which occurred in a 2-year-old boy wit...

Transplant 2004; 33: 1061–1063 15. Ballen KK. New trends in umbilical cord blood transplantation. Blood 2005; 105: 3786–3792 16. Wils EJ, Cornelissen JJ. Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement. Blood Rev 2005; 19: 89–98 17. Mezey E, Chandross KJ, Harta G, Maki RA, Mc Kercher SR. Turning blood into brain: cells bearing neuronal antigens gen...